Juvenile myoclonic epilepsy (JME) is often exquisitely responsive to treatment with valproic acid (VPA). However, a subset of patients does not respond to this medication and often has intractable seizures. We wanted to identify differences between these two subsets of JME patients.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is a common type of epilepsy, representing 26% of idiopathic generalized epilepsies 1 . It typically presents in adolescence with myoclonic seizures with or without absence and generalized tonic-clonic seizures (GTCS). Bilateral and synchronous 4-6/second polyspike and wave complexes characterize the electroencephalogram (EEG) in most patients. Most patients respond to valproic acid (VPA) monotherapy, with excellent seizure control achieved in as high as 82-97% of patients [2] [3] [4] [5] . There is a subset of patients, however, whose seizures do not respond to VPA. This study was undertaken to determine whether there were any differences between these two subgroups of JME patients.
MATERIALS AND METHODS
Charts of all patients with JME followed at the Duke Epilepsy Center were reviewed. Demographic data including sex, age at seizure onset, time to diagnosis of JME, seizure types and characteristics, family history of seizures and assessment of mental functioning were reviewed. VPA responsive patients were defined as those who were seizure free on VPA monotherapy. Included in this group were patients with occasional myoclonus that did not interfere with functioning as well those with breakthrough seizures secondary to noncompliance. VPA resistance was defined as recurrent seizures despite therapeutic levels (50-100 mg dl −1 ) of VPA. Age at seizure onset was defined as the age at which the first seizure was noted, whether myoclonic, absence or generalized tonic-clonic. The time to diag-nosis was defined as the number of years from seizure onset to time diagnosis and/or appropriate therapy, i.e. VPA was instituted, whichever came first.
Unusual seizure characteristics and history were noted. These included previous history of febrile seizures, presence of auras and post-ictal confusion following absence and myoclonic seizures. Additionally, features of focal seizures, i.e. Todd's paralysis, focal motor activity, aphasia, etc., were noted.
Family history of seizures was determined. As most patients were unfamiliar with the type and etiology of seizures in the family members, all relatives with any type of seizure disorder were included.
Mental functioning was assessed based on examiner's mental status examination, school performance (whether patient required special education) and intelligence quotient (IQ) scores when available. Intellectual deficiency was defined as IQ scores less than 80, need for special education classes or mini-mental status scores less than 23.
All EEGs in the VPA resistant group and 81% of the EEGs in the VPA sensitive group were performed at the Duke Epilepsy Center and examined for asymmetries by board-certified electroencephalographers. EEG asymmetry was defined as the presence of consistently unilateral epileptiform discharges independent of the generalized epileptiform activity, focal slowing, and persistent unilateral predominance of bilateral, synchronous polyspike and wave discharges. All magnetic resonance imaging (MRI) reports were reviewed for presence of lesions and other abnormalities.
RESULTS
Thirty-seven patients with JME were identified; two patients with well-controlled JME were excluded since neither had been tried on VPA. The first was unable to afford valproate hence was on lamotrigine through a drug assistance program. The second was a woman of childbearing age who planned to become pregnant and was well controlled on mysoline. Two patients with medically intractable JME were also excluded as both had only very brief trials of VPA and were unable to reach therapeutic levels due to intolerable gastrointestinal side-effects. Of the remaining 33 patients, 23 (70%) were VPA responsive and 10 (30%) were VPA resistant. The summary of results is shown in Table 1 .
Sex
Eighteen females (55%) and 15 (45%) males with JME were identified. There were 10 (43%) males and 13 females (57%) in the VPA sensitive group and 5 (50%) males and 5 (50%) females in the VPA resistant subgroup. Time to diagnosis/treatment of JME
The number of years prior to correct diagnosis and treatment of JME was delayed in most patients to an average of 9.73 years with greater than 2.5 years difference between the two subgroups of patients. The VPA sensitive group were diagnosed and treated earlier with a mean time to diagnosis of 8.91 years (range of 0-52 years, median 3 years) whereas the VPA resistant group were diagnosed and treated at a mean age of 11.60 years (range of 0-28 years, median 7 years).
Family history of seizures
Ten (30%) JME patients had family history of seizures. This was identified in 7 of the 25 (30%) VPA sensitive patients and in 3 of the 10 (30%) VPA resistant patients.
Atypical seizure characteristics
One patient (4%) with VPA sensitive JME reported an aura of a strange cephalic sensation occurring sec-onds to minutes prior to a GTCS. Three (30%) patients in the VPA resistant group had atypical seizure history. One patient reported post-ictal confusion following a series of myoclonic jerks and a second patient described similar confusion following absence seizures. The third patient had history of one febrile and one afebrile seizure at 2.5 years of age.
Intellectual functioning
All patients with VPA sensitive JME had clinically normal intelligence as assessed by examination, school performance and daily functioning. Two patients (20%) in the VPA resistant group had intellectual deficiency with full-scale IQ scores of 64 and 78.
EEG asymmetries
Twenty-one (91%) patients with VPA sensitive JME and all patients with VPA resistant JME had EEGs, 87% of which were done at the Duke Epilepsy Center and were available for review. Among patients in the VPA sensitive group, 2 (10%) had EEGs with focal abnormalities. One patient had occasional right frontotemporal sharp waves. The second patient had left temporal slowing. The latter patient had a closed head injury at 20 years of age (6 years after the onset of JME) with residual mild right hemiparesis. If this patient was excluded, only 1 patient (5%) would have had focal EEG abnormalities in the VPA sensitive group. Among patients in the VPA resistant group, 4 (40%) had focal EEG abnormalities. The focal abnormalities seen in this group were left frontal amplitude predominance of generalized 1.5-6 Hz generalized polyspike and wave discharges; intermittent left temporal slowing; occasional right frontal epileptiform discharges; and left frontotemporal slowing with hyperventilation seen in one patient each.
MRI abnormalities
Five of the VPA sensitive patients had MRIs, 4 of which were normal and 1 (20%) had a smaller left temporal lobe. Nine patients in the VPA resistant group had MRIs, 7 (78%) of which were normal and 2 (22%) had smaller left hippocampus without accompanying signal abnormalities.
DISCUSSION
VPA is the drug of choice for JME with excellent seizure control achieved in 82-97% of JME patients. In this study 30% of the patients were VPA resistant, probably reflecting the higher incidence of medically intractable seizures seen at epilepsy centers. There were no remarkable differences in sex, age of onset, family history of seizures and incidence of MRI abnormalities between the VPA sensitive and resistant JME subgroups.
Studies have identified JME as one of the more common types of epilepsy, accounting for 5-10% of all epilepsies [6] [7] [8] [9] . Though common, JME is often missed and appropriate treatment frequently delayed. Grunewald et al. 10 reported a mean delay in diagnosis of 14.5 years. Delay in diagnosis often occurs due to lack of familiarity with the syndrome, failure to elicit a history of myoclonic jerks and high prevalence of focal abnormalities on EEG. The shorter time to diagnosis seen in our patients probably represents improved awareness of the syndrome at referral centers. Diagnosis was delayed even more in patients with VPA resistant JME. This is likely due to a higher incidence of asymmetric EEG abnormalities, unusual seizure characteristics and intellectual deficiency as noted in the VPA resistant subgroup of this study. These findings may mislead physicians to diagnose a localizationrelated epilepsy in these patients.
As JME is an idiopathic generalized epilepsy, focal features such as aura and post-ictal Todd's paralysis are not expected. However a number of studies have noted focal seizure characteristics in JME patients 11, 12 . Absence seizures in JME are usually of the simple type with rapid return to normal mental status. Panayiotopoulos et al. 13 , however, have described atypical absence seizures in one patient with JME. A higher incidence of febrile seizure (4.4-10%) has been documented in JME as well 1, 4 compared to the overall incidence of 2-5% 14, 15 . This study had similar findings. One patient in the VPA sensitive group had a cephalic sensation prior to GTCS; this finding however can often be seen with GTCS. One patient in the VPA resistant group had post-ictal confusion following absence seizures and another had similar confusion following myoclonic seizures. Another patient in the VPA resistant group had febrile and afebrile seizures at age 2.5 years.
In this study, atypical seizure characteristics were more frequently seen in the VPA resistant group (33% vs. 14%). This raises the issue of whether the VPA resistant JME group is in fact a refractory localizationrelated epilepsy. This may in part explain the resistance to VPA in these patients as VPA, despite being an anticonvulsant with broad spectrum activity, is more effective in primary generalized epilepsy 16 .
Patients with JME have a normal neurologic examination 17 . In this study, one VPA sensitive patient exhibited mild right hemiparesis and left temporal slowing on EEG following a closed head injury. The head injury, which was presumably the cause of the focal slowing, was sustained 6 years after onset of seizures. The rest of the VPA sensitive patients had normal neurologic examinations. Two (20%) patients in the VPA resistant group had IQ scores less than 80, indicating diffuse neuronal dysfunction, raising the suspicion that these patients may have a different form of epilepsy, i.e. a localization-related or symptomatic generalized epilepsy.
Bilateral and synchronous 4-6/second polyspike and wave discharges characterize the EEGs of patients with JME. EEG asymmetries, however, are not uncommon in JME [17] [18] [19] . Aliberti et al. 18 found amplitude asymmetries in the generalized discharges in 72.7% and focal abnormalities in 54.5% of JME patients. Lancman et al. 19 noted EEG asymmetries in 16% of their JME patients. These studies included shifting EEG asymmetries. In this study, focal abnormalities were seen in 40% of the VPA resistant group and only in 10% of the VPA sensitive group. These findings suggest that patients with VPA resistant JME have higher incidence of focal EEG abnormalities, suggestive of a partial epilepsy.
Neuroimaging abnormalities have not been demonstrated in JME patients 20 . In this study one (20%) of the 5 patients with VPA resistant JME who had MRIs had a smaller left temporal lobe though the hippocampi looked symmetric. The significance of this finding was questionable. However 2 (22%) VPA resistant patients had asymmetric hippocampal sizes without signal abnormalities. These focal MRI findings also suggest the possibility of localization-related epilepsy in these patients.
The findings of this study are consistent with Dasheiff and Ritaccio's 21 report of 12 patients with medically intractable JME who had higher incidence of asymmetric EEG abnormalities as well as longer duration of seizures with delay in diagnosis and treatment. In addition to these factors, neurologic abnormalities as well as atypical seizure characteristics and history also appear to be more common in patients with VPA resistant JME.
This study suggests that there are two relatively distinct JME subgroups. The clinical characteristics of the VPA sensitive group resemble the typical JME syndrome described by Janz 22 . The VPA resistant group, however, has a higher incidence of atypical characteristics including asymmetric EEG abnormalities, atypical seizure characteristics and history, and neurological and neuroimaging abnormalities. The presence of these characteristics may help predict which patients will respond to VPA and which ones would require different or additional medications. Whether the VPA resistant subgroup represents atypical JME or a different type of epilepsy (i.e. localization related) remains to be determined.
